MTOR and ovarian carcinoma: Our previous study in ovarian cancer cells found that either the deprivation of glutamine or the inhibition of glutaminolysis by compound 968 significantly reduced cell proliferation and induced apoptosis through AMPK/mTOR/S6 pathway [18, 19].